$146.06
2.44% yesterday
Nasdaq, Nov 25, 10:01 pm CET
ISIN
US7599161095
Symbol
RGEN

Repligen Corporation Stock price

$146.06
+10.61 7.83% 1M
-12.10 7.65% 6M
-33.74 18.77% YTD
-13.40 8.40% 1Y
-125.78 46.27% 3Y
+58.81 67.40% 5Y
+123.32 542.30% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+3.48 2.44%
ISIN
US7599161095
Symbol
RGEN
Sector
Industry

Key metrics

Market capitalization $8.18b
Enterprise Value $8.07b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 61.49
EV/Sales (TTM) EV/Sales 12.74
P/S ratio (TTM) P/S ratio 12.92
P/B ratio (TTM) P/B ratio 4.06
Revenue growth (TTM) Revenue growth -2.91%
Revenue (TTM) Revenue $633.51m
EBIT (operating result TTM) EBIT $27.79m
Free Cash Flow (TTM) Free Cash Flow $131.26m
Cash position $783.96m
EPS (TTM) EPS $-0.15
P/E forward 511.21
P/S forward 12.91
EV/Sales forward 12.74
Short interest 6.89%
Show more

Is Repligen Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Repligen Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Repligen Corporation forecast:

13x Buy
76%
4x Hold
24%

Analyst Opinions

17 Analysts have issued a Repligen Corporation forecast:

Buy
76%
Hold
24%

Financial data from Repligen Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
634 634
5% 5%
100%
- Direct Costs 344 344
5% 5%
54%
290 290
5% 5%
46%
- Selling and Administrative Expenses 132 132
19% 19%
21%
- Research and Development Expense 41 41
5% 5%
7%
116 116
23% 23%
18%
- Depreciation and Amortization 89 89
36% 36%
14%
EBIT (Operating Income) EBIT 28 28
68% 68%
4%
Net Profit -8.10 -8.10
107% 107%
-1%

In millions USD.

Don't miss a Thing! We will send you all news about Repligen Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Repligen Corporation Stock News

Neutral
Seeking Alpha
14 days ago
Repligen Corporation (NASDAQ:RGEN ) Q3 2024 Results Earnings Conference Call November 12, 2024 8:30 AM ET Company Participants Sondra Newman - Vice President, Global Head of Investor Relations Olivier Loeillot - President and Chief Executive Officer Jason Garland - Chief Financial Officer Conference Call Participants Dan Leonard - UBS Dan Arias - Stifel Rachel Vatnsdal - J.P. Morgan Puneet Soud...
Negative
Seeking Alpha
14 days ago
Repligen Corporation is a bioprocessing technology company focusing on process intensification, purification, and fluid management, with strategic acquisitions to enhance its capabilities. Though integration risks remain, RGEN's recent acquisition of Tantti Laboratory aims to bolster its chromatography and biomolecule purification capacities. The potential acquisition of Maravai LifeSciences co...
Neutral
GlobeNewsWire
21 days ago
WALTHAM, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at three upcoming investor conferences.
More Repligen Corporation News

Company Profile

Repligen Corp. provides advanced bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. The firm serves through the following product lines: Chromatography; Filtration; and OEM Products (Proteins). The Chromatography product line includes a number of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The OEM products are represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification, and cell culture growth factor products. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.

Head office United States
CEO Olivier Loeillot
Employees 1,783
Founded 1981
Website www.repligen.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today